Glanbia Stock Forecast for 2023 - 2025 - 2030
Updated on 04/25/2024
Glanbia Stock Forecast and Price Target
Year-long price target forecasts from seven prominent analysts have recently been released for Glanbia, with an average price target of 20.00€. This potential gain of 12.68 percent from the previous closing price in April, 2024 is calculated on a high forecast of 26.00€ and a low estimate of 14.00€. Even if you are not interested in GL9 stock, you should be aware of its competitors and their current standings.
12.68% Upside
Glanbia Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Glanbia's Price has decreased by 100.00%, from 9.86€ to 0.00€. In the next year, analysts are expecting an increase in Fair Value, predicting it will reach 16.93€ – an increase of 100.00%. The Glanbia forecast is for Fair Value to reach 18.57€ or grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| NESN Stock Forecast | Nestlé | Outperform |
11
|
CHF93.98 | Buy/Sell | CHF115.58 | 17.05% |
| KO Stock Forecast | Coca Cola | Outperform |
18
|
$61.55 | Buy/Sell | $65.84 | 7.23% |
| PEP Stock Forecast | PepsiCo | Outperform |
18
|
$177.41 | Buy/Sell | $187.26 | 4.28% |
| ABT Stock Forecast | Abbott Laboratories | Outperform |
9
|
$106.89 | Buy/Sell | $118.92 | 18.35% |
| ULVR Stock Forecast | Unilever PLC | Hold |
8
|
£38.63 | Buy/Sell | £50.61 | 28.55% |
Glanbia Revenue Forecast for 2023 - 2025 - 2030
In the last two years, Glanbia's Revenue has increased by 29.27%, going from 4.20€B to 5.43€B. For the next year, 8 analysts project Glanbia's Revenue to drop by 0.81%, reaching 5.38€B. The Glanbia forecast is for Revenue to reach 5.54€B or grow by 2.07%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| GSK Stock Forecast | GSK | Outperform |
12
|
£16.36 | Buy/Sell | £17.30 | 19.19% |
| 500696 Stock Forecast | Hindustan Unilever | Outperform |
10
|
Rp2.26k | Buy/Sell | Rp2.75k | 15.64% |
| BAS Stock Forecast | BASF | Outperform |
12
|
51.32€ | Buy/Sell | 49.50€ | 9.12% |
.jpg)
Glanbia Dividend per Share Forecast for 2023 - 2025 - 2030
In the last year, Glanbia's Dividend per Share has grown, increasing from 0.29€ to 0.32€ – an increase of 10.34%. For next year, the 8 analysts predict Dividend per Share of 0.37€, which would mean an increase of 15.63%. Over the next nine years, the pros' prediction is Dividend per Shareof 0.41€, which would mean a nine-year growth forecast of 28.38%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BN Stock Forecast | Danone | Outperform |
11
|
59.76€ | Buy/Sell | 55.47€ | 7.10% |
| GIVN Stock Forecast | Givaudan | Hold |
14
|
CHF4.01k | Buy/Sell | CHF3.14k | -3.92% |
| GIS Stock Forecast | General Mills Inc | Hold |
18
|
$71.61 | Buy/Sell | $68.63 | 0.54% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| LONN Stock Forecast | Lonza Group | Buy |
16
|
CHF522.80 | Buy/Sell | CHF516.89 | 11.90% |
| DSFIR Stock Forecast | DSM-Firmenich | Outperform |
18
|
104.00€ | Buy/Sell | 114.60€ | 15.38% |
| NZYM B Stock Forecast | Novozymes A/S | Outperform |
18
|
kr387.90 | Buy/Sell | kr365.54 | 12.14% |
Glanbia EBITDA Forecast for 2023 - 2025 - 2030
In the last two years, Glanbia's EBITDA has grown, increasing from 290.80€M to 521.50€M – a growth of 79.33%. According to 9 major analysts, Glanbia's EBITDA will fall by 8.60% in the next year, reaching 476.66€M. Professionals believe that By 2030, Glanbia's EBITDA will fall to 495.18€M– a 5.05% decrease from its current value.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| IFF Stock Forecast | International Flavors & Fragra... | Hold |
15
|
$85.14 | Buy/Sell | $84.46 | 2.18% |
| MKC Stock Forecast | McCormick & Company | Hold |
12
|
$75.85 | Buy/Sell | $72.03 | -1.12% |
| K Stock Forecast | Kellanova | Hold |
13
|
$58.75 | Buy/Sell | $59.19 | 2.13% |
Glanbia EBIT Forecast for 2023 - 2025 - 2030
In the last two years, Glanbia's EBIT has grown by 89.74%, from 206.70€M to 392.20€M. In the next year, 8 analysts estimate that Glanbia's EBIT will decrease by 7.48%, reaching 362.88€M. Over the next nine years, experts predict that EBIT will grow by 6.64%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| CELH Stock Forecast | Celsius Holdings | Outperform |
13
|
$72.00 | Buy/Sell | $68.64 | 32.29% |
| SY1 Stock Forecast | Symrise | Outperform |
18
|
104.10€ | Buy/Sell | 106.97€ | 8.55% |
| DABUR Stock Forecast | Dabur India | Outperform |
18
|
Rp509.45 | Buy/Sell | Rp607.25 | 17.77% |
Glanbia EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Glanbia's EPS has decreased by 100.00%, from 0.74€ to 0.00€. In the next year, analysts are expecting an increase in EPS, predicting it will reach 1.27€ – an increase of 100.00%. The Glanbia forecast is for EPS to reach 1.39€ or grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| CHR Stock Forecast | Chr. Hansen Holding A/S | - |
16
|
kr549.60 | Buy/Sell | kr71.11 | -100.00% |
| BARN Stock Forecast | Barry Callebaut | Outperform |
18
|
CHF1.38k | Buy/Sell | CHF1.88k | 15.77% |
| GRG Stock Forecast | Greggs | Outperform |
18
|
£27.80 | Buy/Sell | £32.27 | 17.55% |
.jpg)